Hemispherx secures replacement for blood cell supplier BioLife
Hemispherx has signed supply deals with US blood centres to address supply issues that delayed relaunch of genital wart drug, Alferon.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs